Exscientia plc

    Jurisdiction
    United Kingdom
    ISIN
    US30223G1022 (EXAI)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    1 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    4 / 7

    Profile

    Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €19.64M
    Gross margin
    -67.7%
    EBIT
    -€192.91M
    EBIT margin
    -982.2%
    Net income
    -€173.18M
    Net margin
    -881.8%

    Statement period: - (published )

    Dividends

    No dividend payouts

    Earnings Calls

    Latest earnings call: May 24, 2024

    Add to watchlist

    Notifications